Morroniside cinnamic acid conjugate as an anti-inflammatory agent
| dc.creator | Takeda, Yoshinori | |
| dc.creator | Tanigawa, Naomi | |
| dc.creator | Sunghwa, Fortunatus | |
| dc.creator | Ninomiya, Masayuki | |
| dc.creator | Hagiwara, Makoto | |
| dc.creator | Matsushita, Kenji | |
| dc.creator | Koketsu, Mamoru | |
| dc.date | 2016-07-21T18:18:07Z | |
| dc.date | 2016-07-21T18:18:07Z | |
| dc.date | 2010-08 | |
| dc.date.accessioned | 2018-03-27T08:54:57Z | |
| dc.date.available | 2018-03-27T08:54:57Z | |
| dc.description | Full text can be accessed at http://www.sciencedirect.com/science/article/pii/S0960894X10008693 | |
| dc.description | A morroniside cinnamic acid conjugate was prepared and evaluated on E-selectin mediated cell-cell adhesion as an important role in inflammatory processes. 7-O-Cinnamoylmorroniside exhibited excellent anti-inflammatory activity (IC(50)=49.3 microM) by inhibiting the expression of E-selectin; further, it was more active than another cinnamic-acid-conjugated iridoid glycoside (harpagoside; IC(50)=88.2 microM), 7-O-methylmorroniside, and morroniside itself. As a result, 7-O-cinnamoylmorroniside was observed to be a potent inhibitor of TNF-alpha-induced E-selectin expression. | |
| dc.identifier | Takeda, Y., Tanigawa, N., Sunghwa, F., Ninomiya, M., Hagiwara, M., Matsushita, K. and Koketsu, M., 2010. Morroniside cinnamic acid conjugate as an anti-inflammatory agent. Bioorganic & medicinal chemistry letters, 20(16), pp.4855-4857. | |
| dc.identifier | http://hdl.handle.net/20.500.11810/3367 | |
| dc.identifier | 10.1016/j.bmcl.2010.06.095 ยท Source: PubMed | |
| dc.identifier.uri | http://hdl.handle.net/20.500.11810/3367 | |
| dc.language | en | |
| dc.subject | Morroniside | |
| dc.subject | 7-O-Cinnamoylmorroniside | |
| dc.subject | Anti-inflammatory activity | |
| dc.title | Morroniside cinnamic acid conjugate as an anti-inflammatory agent | |
| dc.type | Journal Article |